Literature DB >> 20478472

ICRP publication 112. A report of preventing accidental exposures from new external beam radiation therapy technologies.

P Ortiz López, J M Cosset, P Dunscombe, O Holmberg, J C Rosenwald, L Pinillos Ashton, J J Vilaragut Llanes, S Vatnitsky.   

Abstract

Disseminating the knowledge and lessons learned from accidental exposures is crucial in preventing re-occurrence. This is particularly important in radiation therapy; the only application of radiation in which very high radiation doses are deliberately given to patients to achieve cure or palliation of disease. Lessons from accidental exposures are, therefore, an invaluable resource for revealing vulnerable aspects of the practice of radiotherapy, and for providing guidance for the prevention of future occurrences. These lessons have successfully been applied to avoid catastrophic events with conventional technologies and techniques. Recommendations, for example, include the independent verification of beam calibration and independent calculation of the treatment times and monitor units for external beam radiotherapy, and the monitoring of patients and their clothes immediately after brachytherapy. New technologies are meant to bring substantial improvement to radiation therapy. However, this is often achieved with a considerable increase in complexity, which in turn brings opportunities for new types of human error and problems with equipment. Dissemination of information on these errors or mistakes as soon as it becomes available is crucial in radiation therapy with new technologies. In addition, information on circumstances that almost resulted in serious consequences (near-misses) is also important, as the same type of events may occur elsewhere. Sharing information about near-misses is thus a complementary important aspect of prevention. Lessons from retrospective information are provided in Sections 2 and 4 of this report. Disseminating lessons learned for serious incidents is necessary but not sufficient when dealing with new technologies. It is of utmost importance to be proactive and continually strive to answer questions such as 'What else can go wrong', 'How likely is it?' and 'What kind of cost-effective choices do I have for prevention?'. These questions are addressed in Sections 3 and 5 of this report. Section 6 contains the conclusions and recommendations. This report is expected to be a valuable resource for radiation oncologists, hospital administrators, medical physicists, technologists, dosimetrists, maintenance engineers, radiation safety specialists, and regulators. While the report applies specifically to new external beam therapies, the general principles for prevention are applicable to the broad range of radiotherapy practices where mistakes could result in serious consequences for the patient and practitioner.

Entities:  

Mesh:

Year:  2009        PMID: 20478472     DOI: 10.1016/j.icrp.2010.02.002

Source DB:  PubMed          Journal:  Ann ICRP        ISSN: 0146-6453


  36 in total

1.  [Rules and regulations applying to incidents in radiotherapy].

Authors:  F Lohr; W Baus; H Vorwerk; B Schlömp; L André; D Georg; N Hodapp
Journal:  Strahlenther Onkol       Date:  2012-05-16       Impact factor: 3.621

2.  Failure modes and effects analysis of total skin electron irradiation technique.

Authors:  B Ibanez-Rosello; J A Bautista; J Bonaque; J Perez-Calatayud; A Gonzalez-Sanchis; J Lopez-Torrecilla; L Brualla-Gonzalez; T Garcia-Hernandez; A Vicedo-Gonzalez; D Granero; A Serrano; B Borderia; C Solera; J Rosello
Journal:  Clin Transl Oncol       Date:  2017-08-04       Impact factor: 3.405

3.  The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management.

Authors:  M Saiful Huq; Benedick A Fraass; Peter B Dunscombe; John P Gibbons; Geoffrey S Ibbott; Arno J Mundt; Sasa Mutic; Jatinder R Palta; Frank Rath; Bruce R Thomadsen; Jeffrey F Williamson; Ellen D Yorke
Journal:  Med Phys       Date:  2016-07       Impact factor: 4.071

4.  Quality and safety in stereotactic radiosurgery and stereotactic body radiation therapy: can more be done?

Authors:  Timothy D Solberg; Paul M Medin
Journal:  J Radiosurg SBRT       Date:  2011

5.  A validation study of a dedicated software for an automated in vivo dosimetry control in radiotherapy.

Authors:  A Piermattei; F Greco; M Grusio; S Menna; L Azario; G Stimato; E Placidi; S Teodoli; S Cilla; A Porcelli; L Alberico; A Fidanzio
Journal:  Med Biol Eng Comput       Date:  2018-04-23       Impact factor: 2.602

Review 6.  Patient safety in radiation oncology in Spain: a need to change.

Authors:  J Pardo Masferrer; E Del Cerro Peñalver; J Contreras Martinez; C Ferrer Albiach
Journal:  Clin Transl Oncol       Date:  2019-07-19       Impact factor: 3.405

7.  Redesign of process map to increase efficiency: Reducing procedure time in cervical cancer brachytherapy.

Authors:  Antonio L Damato; Larissa J Lee; Mandar S Bhagwat; Ivan Buzurovic; Robert A Cormack; Susan Finucane; Jorgen L Hansen; Desmond A O'Farrell; Alecia Offiong; Una Randall; Scott Friesen; Akila N Viswanathan
Journal:  Brachytherapy       Date:  2015-01-06       Impact factor: 2.362

8.  Usability of detecting delivery errors during treatment of prostate VMAT with a gantry-mounted transmission detector.

Authors:  Hirofumi Honda; Masahide Tominaga; Motoharu Sasaki; Masataka Oita; Hiromitsu Kanzaki; Yasushi Hamamoto; Yoshiaki Ishii; Ryuji Yamamoto; Teruhito Mochizuki; Teruhito Kido; Yoshihiro Uto
Journal:  J Appl Clin Med Phys       Date:  2021-05-05       Impact factor: 2.102

9.  Recommendations for safer radiotherapy: what's the message?

Authors:  Peter Dunscombe
Journal:  Front Oncol       Date:  2012-09-28       Impact factor: 6.244

10.  Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy.

Authors:  Marie Claire Cantone; Mario Ciocca; Francesco Dionisi; Piero Fossati; Stefano Lorentini; Marco Krengli; Silvia Molinelli; Roberto Orecchia; Marco Schwarz; Ivan Veronese; Viviana Vitolo
Journal:  Radiat Oncol       Date:  2013-05-24       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.